{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:06:57Z","timestamp":1789160817946,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004823","name":"Connecticut State Department of Mental Health and Addiction Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA047621"],"award-info":[{"award-number":["R21 DA047621"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA046030"],"award-info":[{"award-number":["R21 DA046030"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 MH110674"],"award-info":[{"award-number":["R01 MH110674"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K99\/R00 DA048125"],"award-info":[{"award-number":["K99\/R00 DA048125"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbih.2026.101337","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:47:47Z","timestamp":1787701667000},"page":"101337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preliminary evidence of neuroimmune system disruption in opioid use disorder: Findings from a pilot PET TSPO imaging study"],"prefix":"10.1016","volume":"56","author":[{"given":"Eric","family":"Woodcock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Matuskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheila","family":"Najafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Labaree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansel T.","family":"Hillmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-9878","authenticated-orcid":false,"given":"Gustavo A.","family":"Angarita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbih.2026.101337_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1139\/cjpp-2015-0209","article-title":"Administration of the glial cell modulator, minocycline, in the nucleus accumbens attenuated the maintenance and reinstatement of morphine-seeking behavior","volume":"94","author":"Arezoomandan","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib2","first-page":"67","article-title":"Acute morphine exposure increases the brain distribution of [18F]DPA-714, a PET biomarker of glial activation in nonhuman Primates","volume":"20","author":"Auvity","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib3","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1038\/s41467-020-15930-5","article-title":"PTSD is associated with neuroimmune suppression: evidence from PET imaging and postmortem transcriptomic studies","volume":"11","author":"Bhatt","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbih.2026.101337_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.bbi.2009.01.014","article-title":"The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release","volume":"23","author":"Bland","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.bbih.2026.101337_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/bmjspcare-2013-000573","article-title":"A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function","volume":"4","author":"Boland","year":"2014","journal-title":"BMJ Support. Palliat. Care"},{"issue":"3","key":"10.1016\/j.bbih.2026.101337_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.23907\/2012.035","article-title":"Neuropathological alterations in illicit drug abuse","volume":"2","author":"B\u00fcttner","year":"2012","journal-title":"Academic Forensic Pathology"},{"key":"10.1016\/j.bbih.2026.101337_bib7","series-title":"IEEE Nucl. Sci. Symp. Conf. Rec., M16-6","article-title":"Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction of the HRRT","author":"Carson","year":"2003"},{"issue":"7","key":"10.1016\/j.bbih.2026.101337_bib8","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.4049\/jimmunol.1302647","article-title":"Buprenorphine decreases the CCL2-Mediated chemotactic response of monocytes","volume":"194","author":"Carvallo","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bbih.2026.101337_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/adb.12261","article-title":"The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid\u2010dependent volunteers","volume":"21","author":"Cooper","year":"2016","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bbih.2026.101337_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.drugalcdep.2017.04.029","article-title":"Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers","volume":"178","author":"Cooper","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.bbih.2026.101337_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11845-015-1314-5","article-title":"Demographic and clinical factors predicting retention in methadone maintenance: results from an Irish cohort","volume":"185","author":"Darker","year":"2016","journal-title":"Ir. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.bbih.2026.101337_bib12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1088\/0031-9155\/52\/5\/019","article-title":"Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner","volume":"52","author":"de Jong","year":"2007","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.bbih.2026.101337_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neubiorev.2018.09.006","article-title":"The role of inflammation in core features of depression: insights from paradigms using exogenously-induced inflammation","volume":"94","author":"Dooley","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbih.2026.101337_bib14","series-title":"Structured Clinical Interview for DSM-5, Research Version","author":"First","year":"2015"},{"issue":"6","key":"10.1016\/j.bbih.2026.101337_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12832","article-title":"Stress-related suppression of peripheral cytokines predicts future relapse in alcohol-dependent individuals with and without subclinical depression","volume":"25","author":"Fox","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.bbih.2026.101337_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2013.06.010","article-title":"The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [C]PBR28 PET study","author":"Hannestad","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13550-017-0305-0","article-title":"Microglial depletion and activation: a [11C]PBR28 PET study in nonhuman primates","volume":"7","author":"Hillmer","year":"2017","journal-title":"EJNMMI Res."},{"issue":"8","key":"10.1016\/j.bbih.2026.101337_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2967\/jnumed.119.237735","article-title":"Tobacco smoking in people is not associated with altered 18-kDa translocator protein levels: a PET study","volume":"61","author":"Hillmer","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"12","key":"10.1016\/j.bbih.2026.101337_bib19","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/mp.2017.10","article-title":"In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependence","volume":"22","author":"Hillmer","year":"2017","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.bbih.2026.101337_bib20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00004728-199803000-00032","article-title":"Enhancement of MR images using registration for signal averaging [comparative study research support, non-U.S. Gov't research support, U.S. Gov't, non-P.H.S. research support, U.S. Gov't, P.H.S.]","volume":"22","author":"Holmes","year":"1998","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biopsych.2017.08.005","article-title":"Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study","volume":"83","author":"Holmes","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.bbih.2026.101337_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuropharm.2013.05.039","article-title":"Why is neuroimmunopharmacology crucial for the future of addiction research?","volume":"76","author":"Hutchinson","year":"2014","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.bbih.2026.101337_bib24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/JLB.3HI0118-015R","article-title":"Frontline science: buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes","volume":"104","author":"Jaureguiberry-Bravo","year":"2018","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.bbih.2026.101337_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.bbih.2026.101337_bib26","doi-asserted-by":"crossref","DOI":"10.1118\/1.4819820","article-title":"Evaluation of motion correction methods in human brain PET imaging--a simulation study based on human motion data","volume":"40","author":"Jin","year":"2013","journal-title":"Med. Phys."},{"issue":"4","key":"10.1016\/j.bbih.2026.101337_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jid.2015.36","article-title":"The use of luminex assays to measure cytokines","volume":"135","author":"Khalifian","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/npp.2016.121","article-title":"Glial and neuroimmune mechanisms as critical modulators of drug use and abuse","volume":"42","author":"Lacagnina","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00259-021-05408-x","article-title":"Contribution of TSPO imaging in the understanding of the state of gliosis in substance use disorders","volume":"49","author":"Leroy","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"11","key":"10.1016\/j.bbih.2026.101337_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172884","article-title":"Imaging neuroinflammation in individuals with substance use disorders","volume":"134","author":"Li","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.bbih.2026.101337_bib31","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1038\/s41380-020-00914-0","article-title":"Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis","volume":"26","author":"Lizano","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"9","key":"10.1016\/j.bbih.2026.101337_bib32","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/npp.2017.70","article-title":"Effects of ibudilast on the subjective, reinforcing, and analgesic effects of oxycodone in recently detoxified adults with opioid dependence","volume":"42","author":"Metz","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.bbih.2026.101337_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030571","article-title":"Dual roles of astrocyte-derived factors in regulation of blood-brain barrier function after brain damage","volume":"20","author":"Michinaga","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/HRP.0000000000000323","article-title":"The effects of peripheral inflammation on the Brain-A neuroimaging perspective","volume":"30","author":"Millett","year":"2022","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.bbih.2026.101337_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.rvsc.2015.01.010","article-title":"Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis, or neutrophil phagocytic function in healthy dogs","volume":"99","author":"Monibi","year":"2015","journal-title":"Res. Vet. Sci."},{"issue":"11","key":"10.1016\/j.bbih.2026.101337_bib36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/jnen\/nlz084","article-title":"Drug abuse-related neuroinflammation in human postmortem brains: an immunohistochemical approach","volume":"78","author":"Moretti","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"30","key":"10.1016\/j.bbih.2026.101337_bib37","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1523\/JNEUROSCI.0928-14.2014","article-title":"Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C] PBR28","volume":"34","author":"Narendran","year":"2014","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbih.2026.101337_bib38","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00213-005-2239-x","article-title":"Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers","volume":"179","author":"Neri","year":"2005","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.bbih.2026.101337_bib39","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/jcbfm.2014.46","article-title":"Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study","volume":"34","author":"Owen","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","article-title":"An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28","volume":"32","author":"Owen","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.bbih.2026.101337_bib41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00259-015-3043-4","article-title":"11C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas","volume":"42","author":"Park","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"2020","key":"10.1016\/j.bbih.2026.101337_bib42","article-title":"Effects of Drugs of Abuse on the Blood-Brain Barrier: A Brief Overview [Mini Review]","volume":"14","author":"Pimentel","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbih.2026.101337_bib43","article-title":"Opioids and the immune system\u2013friend or foe","author":"Plein","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.bbih.2026.101337_bib44","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system - friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"8_Suppl. l","key":"10.1016\/j.bbih.2026.101337_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the immune system","volume":"20","author":"Sacerdote","year":"2006","journal-title":"Palliat. Med."},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/SPC.0b013e3282f5272e","article-title":"Opioid-induced immunosuppression","volume":"2","author":"Sacerdote","year":"2008","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"4","key":"10.1016\/j.bbih.2026.101337_bib47","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbi.2007.12.013","article-title":"Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function","volume":"22","author":"Sacerdote","year":"2008","journal-title":"Brain Behav. Immun."},{"issue":"40","key":"10.1016\/j.bbih.2026.101337_bib48","doi-asserted-by":"crossref","first-page":"12468","DOI":"10.1073\/pnas.1511003112","article-title":"Imaging robust microglial activation after lipopolysaccharide administration in humans with PET","volume":"112","author":"Sandiego","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbih.2026.101337_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1073858420914747","article-title":"Neuroimmune interactions in pain and stress: an interdisciplinary approach","volume":"27","author":"Sawicki","year":"2021","journal-title":"Neuroscientist"},{"issue":"4","key":"10.1016\/j.bbih.2026.101337_bib50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1037\/1064-1297.3.4.424","article-title":"Measurement of drug craving during naloxone-precipitated withdrawal in methadone-maintained volunteers","volume":"3","author":"Schuster","year":"1995","journal-title":"Exp. Clin. Psychopharmacol"},{"issue":"16","key":"10.1016\/j.bbih.2026.101337_bib51","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1007\/s00213-014-3490-9","article-title":"Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties","volume":"231","author":"Seleman","year":"2014","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.bbih.2026.101337_bib52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.biopsych.2021.06.007","article-title":"Transcriptional alterations in dorsolateral prefrontal cortex and nucleus accumbens implicate neuroinflammation and synaptic remodeling in opioid use disorder","volume":"90","author":"Seney","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbih.2026.101337_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1196\/annals.1369.020","article-title":"Alterations in blood-brain barrier function by morphine and methamphetamine","volume":"1074","author":"Sharma","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.bbih.2026.101337_bib54","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v10i8.2955","article-title":"Is the neuroimmune system a therapeutic target for opioid use disorder? A systematic review","volume":"10","author":"Toloff","year":"2022","journal-title":"Medical Research Archives"},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.bbih.2026.101337_bib57","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am. J. Therapeut."},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.bbih.2026.101337_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/adb.70033","article-title":"Ibudilast-mediated suppression of neuronal TLR4 in the prefrontal cortex mitigates methamphetamine-induced neuroinflammation and addictive behaviours","volume":"30","author":"Wang","year":"2025","journal-title":"Addict. Biol."},{"issue":"16","key":"10.1016\/j.bbih.2026.101337_bib60","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1073\/pnas.1200130109","article-title":"Morphine activates neuroinflammation in a manner parallel to endotoxin","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbih.2026.101337_bib61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mito.2023.01.007","article-title":"Mitochondrial oxidative stress in brain microvascular endothelial cells: triggering blood-brain barrier disruption","volume":"69","author":"Wang","year":"2023","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.bbih.2026.101337_bib62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1361-8415(01)80004-9","article-title":"Multi-modal volume registration by maximization of mutual information [Case Reports Comparative StudyResearch Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]","volume":"1","author":"Wells","year":"1996","journal-title":"Med. Image Anal."},{"issue":"2","key":"10.1016\/j.bbih.2026.101337_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.bbih.2026.101337_bib64","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbi.2020.09.027","article-title":"Acute neuroimmune stimulation impairs verbal memory in adults: a PET brain imaging study","volume":"91","author":"Woodcock","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbih.2026.101337_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2022.12.030","article-title":"Opioid-induced fragile-like regulatory T cells contribute to withdrawal","volume":"186","author":"Zhu","year":"2023","journal-title":"Cell"}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626001705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626001705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:17:51Z","timestamp":1789157871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354626001705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":64,"alternative-id":["S2666354626001705"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101337","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary evidence of neuroimmune system disruption in opioid use disorder: Findings from a pilot PET TSPO imaging study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101337"}}